Xv Technology News Today

The New Criterion's Tim Boreham uncovers the potential of 4D Medical in the USA

Global medtech company 4D Medical, creator of lung function imaging technology, has announced a merger with Imbio, reporting that combining existing technologies will drive respiratory health improvements around the globe.

/PRNewswire/ -- Imbio, Inc. (a portfolio company of Minneapolis-based Invenshure LLC), a provider of medical imaging analysis technologies for chronic lung and...

A producer of advanced lung function imaging software, 4D Medical has received U.S Food and Drug Administration (FDA) clearance for its CT-based ventilation product (CT LVAS). The company’s software scans, analyzes CT images providing rich data on regional lung function, enabling radiologists to furnish new levels of quantified, data-based correlation between function and structure to patients' physicians, using existing CT scanning equipment, according to a company statement released No...

/PRNewswire/ -- 4DMedical, the leading producer of advanced lung function imaging software has received FDA clearance for its CT-based ventilation product (CT...

ASX opens higher following strong finish on Wall Street over the weekend. Earnings season continues with Origin, Judo, Sezzle, Santos featuring.

The ASX 200 opens strongly on Tuesday. Consumer sentiment rallies following RBA rate hike pause. Evergreen Lithium debuts on ASX.

This ASX healthcare share is rocketing ahead on the market today. Let's check what's behind the investor optimism.

Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session addresses, the Imaging Technology news (ITN) editorial team offers this snapshot of noteworthy highlights from day one of the RSNA 108th Scientific Assembly and Annual Meeting, which reported 34,385 total advanced registrants for the Nov. 27-Dec. 1 conference being held at McCormick Place in Chicago, IL.

/PRNewswire/ -- 4DMedical, the leading developer of functional imaging software for respiratory illness, announced successful completion of a study by...